Issue: February 2014
February 01, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
VISTA-16
Issue: February 2014
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Study of the CV outcomes associated with secretory phospholipase A2 inhibition with varespladib.
